A Democratic bill with 1 Republican cosponsor · See all 5 cosponsors
Last activity — Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
In committee
Introduced and handed to a committee in the chamber it started in.
The committee holds it, and most bills are never heard from again. A hearing or a committee vote would be news; silence is the usual outcome, and it kills the bill without anyone voting against it.
Its path through Congress
- Introduced
- In Committee
What this bill would do
The "Stop CMV Act of 2025" amends the Public Health Service Act to allow hospitals and health care entities to test infants 21 days old or younger for congenital Cytomegalovirus. State health officers can set the standards for testing, recording results, and educating parents. If a state fails to set these standards within two years, an Advisory Committee will do so. The bill provides grants through the Health Resources and Services Administration and the CDC for testing and technical assistance. Additionally, the National Institutes of Health will research new screening techniques, diagnostics, and treatments.
Yes· 3 of 12
- Scored +10
Would children be better off under this?
Directly benefits newborns through early screening and potential treatment for a serious congenital virus.
- Scored +7
Does this put more money into medical research?
The bill mandates the NIH to establish or expand research programs for CMV diagnostics, prevention, and treatments.
- Scored +7
Does this put more money into scientific research?
The bill specifically authorizes funding and research programs for CMV screening and treatments via the NIH.
The opposite
No question was scored the opposite.
Who it would affect, and how
Potential Positive Impacts for People
-
Newborn Screening: Hospitals and health care entities can administer tests for congenital Cytomegalovirus to infants 21 days or younger, which helps in identifying the condition early (Sec. 2(a)).
-
Public Education: Grants from the CDC will provide technical assistance to educate health care providers, patients, and the general public on preventing, diagnosing, and treating the virus (Sec. 2(c)(2)(A)(ii)).
-
Medical Research: The National Institutes of Health will fund research into new screening technology, vaccine development, and cures or treatments for the virus both during pregnancy and after birth (Sec. 2(c)(3)(A)).
-
Financial Support: Grants will be awarded to States to help entities administer the required tests (Sec. 2(c)(1)(A)).
Potential Negative Impacts for People
- No negative impacts for individuals or groups are explicitly mentioned in the provided text.
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Tap or hover a score for the reason it gave.
- Demographic And Interest Groups
- Would children be better off under this? — Directly benefits newborns through early screening and potential treatment for a serious congenital virus. Would people with disabilities be better off under this? — Aims to prevent the onset of disabilities caused by congenital CMV through early detection. Would women be better off under this? — Benefits mothers through improved neonatal care and research into prevention during pregnancy. Would high-income households be better off under this? — Improves health outcomes for infants through standardized screening. Would households on low incomes be better off under this? — Federal grants for testing and technical assistance reduce the financial burden on families for early screening. Would middle-income households be better off under this? — Improves health outcomes for infants through standardized screening.
- Healthcare
- Does this put more money into medical research? — The bill mandates the NIH to establish or expand research programs for CMV diagnostics, prevention, and treatments. Does this make health care easier to get in general? — The bill expands access to essential newborn screening for congenital Cytomegalovirus.
- Education And Technology
- Does this put more money into scientific research? — The bill specifically authorizes funding and research programs for CMV screening and treatments via the NIH.
- Governance And Ideology
- Does this leave more decisions to the states? — The bill allows state health officers to prescribe their own standards for testing. Does this give the federal government more power? — The federal government provides guidelines and takes over standard-setting if states fail to do so.
- Social Issues And Justice
- Does this expand the rights of people with disabilities? — Early detection of CMV can prevent or mitigate lifelong disabilities associated with the virus.
- 11/9/2026
- 1 Cosponsor added.
- 3/17/2026
- 1 Cosponsor added.
- 10/14/2025
- 1 Cosponsor added.
- 9/17/2025
- Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- 2 Cosponsors added.
- Introduced in Senate
One bill Congress.gov lists as related to this one — companions in the other chamber, earlier versions, and bills this one absorbed or was folded into.
Christopher CoonsDemocrat · Delaware
Amy KlobucharDemocrat · Minnesota
Mark KellyDemocrat · Arizona
Christopher MurphyDemocrat · Connecticut
Roger MarshallRepublican · Kansas